MYRIAD GENETICS INC

MYGN

In Vitro & In Vivo Diagnostic Substances(DE)CIK: 899923

Revenue (Latest FY)

$753.2M

Net Income (Latest FY)

-$263.3M

Industry

In Vitro & In Vivo Diagnostic Substances

Recent Filings

Company Details

CIK899923

Fiscal Year End1231

CategoryAccelerated filer

StateDE

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)